Harbour Capital Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$239K Buy
+575
New +$213K 0.04% 275
2026
Q1
Sell
-577
Closed -$204K 290
2025
Q4
$204K Hold
577
0.04% 268
2025
Q3
$206K Buy
577
+2
+0.3% +$622 0.04% 272
2025
Q2
$201K Hold
575
0.04% 283
2025
Q1
$260K Buy
+575
New +$231K 0.06% 237
2024
Q4
Sell
-500
Closed -$247K 287
2024
Q3
$247K Hold
500
0.06% 255
2024
Q2
$267K Hold
500
0.06% 238
2024
Q1
$250K Hold
500
0.06% 247
2023
Q4
$240K Hold
500
0.07% 241
2023
Q3
$218K Hold
500
0.07% 241
2023
Q2
$222K Hold
500
0.07% 235
2023
Q1
$230K Hold
500
0.07% 237
2022
Q4
$251K Hold
500
0.08% 198
2022
Q3
$234K Hold
500
0.08% 195
2022
Q2
$241K Hold
500
0.08% 193
2022
Q1
$246K Hold
500
0.07% 202
2021
Q4
$232K Buy
+500
New +$210K 0.06% 221
2017
Q2
Sell
-500
Closed -$82.7K 336
2017
Q1
$82.7K Buy
+500
New +$79.5K 0.04% 314
2015
Q4
Sell
-5,380
Closed -$753K 229
2015
Q3
$753K Hold
5,380
0.53% 68
2015
Q2
$883K Sell
5,380
-75
-1% -$12K 0.55% 60
2015
Q1
$842K Sell
5,455
-5,745
-51% -$818K 0.59% 52
2014
Q4
$1.41M Sell
11,200
-165
-1% -$20.4K 1.01% 15
2014
Q3
$1.36M Buy
11,365
+145
+1% +$16.6K 1.12% 12
2014
Q2
$1.21M Buy
11,220
+725
+7% +$74.7K 0.95% 16
2014
Q1
$1.04M Buy
10,495
+1,500
+17% +$136K 0.99% 16
2013
Q4
$831K Buy
8,995
+1,150
+15% +$102K 0.73% 35
2013
Q3
$656K Buy
7,845
+950
+14% +$81.4K 0.72% 42
2013
Q2
$564K Buy
+6,895
New +$516K 0.71% 43

Other funds holding ELV

Harbour Capital Advisors's ELV Position: Q2 2026 in Review

Harbour Capital Advisors opened a new position in Elevance Health (ELV) in Q2 2026: 575 shares worth $239K. The stake represents 0.04% of the portfolio and ranks #275 among its holdings. This is a return to the name: Harbour Capital Advisors previously reported a position in ELV as recently as Q4 2025.

Harbour Capital Advisors first reported a position in ELV in Q2 2013 and has held it in 28 quarters since. The position peaked at $1.41M in Q4 2014. 331 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Harbour Capital Advisors held 575 shares of Elevance Health worth $239K as of Q2 2026.
  • Elevance Health was a new Harbour Capital Advisors position in Q2 2026.
  • Elevance Health made up 0.04% of Harbour Capital Advisors's portfolio in Q2 2026, its #275 holding.
  • Harbour Capital Advisors first reported a position in Elevance Health in Q2 2013 and has held it in 28 quarters since.
  • Harbour Capital Advisors's Elevance Health position peaked at $1.41M in Q4 2014.
  • 331 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Harbour Capital Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.